• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脯氨酸突变 LR 肽抑制人胸苷酸合成酶和卵巢癌细胞生长的构象倾向和生物学研究。

Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth.

机构信息

Department of Life Sciences , University of Modena and Reggio Emilia , Via Campi 103 , 41125 Modena , Italy.

Department of Biomedical Sciences, Metabolic and Neural Sciences , University of Modena and Reggio Emilia , Via Campi 287 , 41125 Modena , Italy.

出版信息

J Med Chem. 2018 Aug 23;61(16):7374-7380. doi: 10.1021/acs.jmedchem.7b01699. Epub 2018 Aug 13.

DOI:10.1021/acs.jmedchem.7b01699
PMID:30035541
Abstract

LR and [d-Gln]LR peptides bind the monomer-monomer interface of human thymidylate synthase and inhibit cancer cell growth. Here, proline-mutated LR peptides were synthesized. Molecular dynamics calculations and circular dichroism spectra have provided a consistent picture of the conformational propensities of the [Pro ]-peptides. [Pro]LR and [Pro]LR show improved cell growth inhibition and similar intracellular protein modulation compared with LR. These represent a step forward to the identification of more rigid and metabolically stable peptides.

摘要

LR 和 [d-Gln]LR 肽结合人胸苷酸合成酶单体-单体界面并抑制癌细胞生长。本文合成了脯氨酸突变的 LR 肽。分子动力学计算和圆二色谱谱图为 [Pro]-肽的构象倾向提供了一致的图像。与 LR 相比,[Pro]LR 和 [Pro]LR 显示出更好的细胞生长抑制作用和相似的细胞内蛋白调节作用。这代表着向鉴定更刚性和代谢更稳定的肽迈出了一步。

相似文献

1
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth.脯氨酸突变 LR 肽抑制人胸苷酸合成酶和卵巢癌细胞生长的构象倾向和生物学研究。
J Med Chem. 2018 Aug 23;61(16):7374-7380. doi: 10.1021/acs.jmedchem.7b01699. Epub 2018 Aug 13.
2
Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth.优化靶向人胸苷酸合成酶的肽以抑制卵巢癌细胞生长。
J Med Chem. 2014 Feb 27;57(4):1355-67. doi: 10.1021/jm401574p. Epub 2014 Feb 12.
3
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.环肽作为人类胸苷酸合成酶和癌细胞生长的变构抑制剂。
Molecules. 2019 Sep 26;24(19):3493. doi: 10.3390/molecules24193493.
4
Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides.通过质谱分析/生物信息学鉴定表征抗癌肽细胞活性的蛋白质亚群。
J Proteome Res. 2014 Nov 7;13(11):5250-61. doi: 10.1021/pr500510v. Epub 2014 Sep 29.
5
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.蛋白-蛋白界面结合肽抑制癌症治疗靶点人胸苷酸合成酶。
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E542-9. doi: 10.1073/pnas.1104829108. Epub 2011 Jul 27.
6
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.叶酸-肽缀合物将选择性癌细胞内化与胸苷酸合成酶二聚体界面靶向结合。
J Med Chem. 2021 Mar 25;64(6):3204-3221. doi: 10.1021/acs.jmedchem.0c02107. Epub 2021 Mar 12.
7
Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase.一种 obligate 同二聚体抗癌靶点中的热点。人胸苷酸合成酶中界面突变的结构和功能影响。
J Med Chem. 2015 Apr 23;58(8):3572-81. doi: 10.1021/acs.jmedchem.5b00137. Epub 2015 Apr 1.
8
Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model.腹腔注射DFP-10825(一种靶向胸苷酸合成酶的阳离子脂质体偶联RNAi分子)对腹膜播散性卵巢癌异种移植模型的抗癌活性。
Drug Des Devel Ther. 2018 Mar 29;12:673-683. doi: 10.2147/DDDT.S156635. eCollection 2018.
9
Internalization and stability of a thymidylate synthase Peptide inhibitor in ovarian cancer cells.胸苷酸合成酶肽抑制剂在卵巢癌细胞中的内化和稳定性。
J Med Chem. 2014 Dec 26;57(24):10551-6. doi: 10.1021/jm501397h. Epub 2014 Dec 3.
10
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.人类胸苷酸合成酶抑制剂可阻止卵巢癌生长。
Vitam Horm. 2018;107:473-513. doi: 10.1016/bs.vh.2017.12.002. Epub 2018 Feb 12.

引用本文的文献

1
[A pedigree study of laryngo-onycho-cutaneous syndrome with a novel mutation on LAMA3 gene].[一项关于伴有LAMA3基因新突变的喉-甲-皮肤综合征的家系研究]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Mar;36(3):212-216. doi: 10.13201/j.issn.2096-7993.2022.03.011.
2
DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle.DTYMK 通过调节细胞周期促进肝癌细胞增殖。
Cell Cycle. 2021 Sep;20(17):1681-1691. doi: 10.1080/15384101.2021.1958502. Epub 2021 Aug 9.
3
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.
叶酸-肽缀合物将选择性癌细胞内化与胸苷酸合成酶二聚体界面靶向结合。
J Med Chem. 2021 Mar 25;64(6):3204-3221. doi: 10.1021/acs.jmedchem.0c02107. Epub 2021 Mar 12.
4
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.环肽作为人类胸苷酸合成酶和癌细胞生长的变构抑制剂。
Molecules. 2019 Sep 26;24(19):3493. doi: 10.3390/molecules24193493.
5
Correlation of with onset and prognosis of ovarian cancer.与卵巢癌发病及预后的相关性。 (你提供的原文“Correlation of with onset and prognosis of ovarian cancer.”中“of”后面缺少具体内容,我按照完整语义进行了翻译,你可根据实际情况补充完整原文信息。)
Oncol Lett. 2019 Sep;18(3):2813-2818. doi: 10.3892/ol.2019.10600. Epub 2019 Jul 10.